Longo LVG, Hughes T, McNeil-Laidley B, Cottini F, Hilinski G, Merritt E, Benson DM. TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma. haematol [Internet]. 2024Feb.1 [cited 2024Nov.8];109(2):578-90. Available from: https://haematologica.org/article/view/haematol.2023.282838